Maluba, Mahdoda .
HRN: 21-95-53 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/13/2022
CEFTRIAXONE 1G (VIAL)
10/13/2022
10/20/2022
IV
2g
Q24H
T/C Acute Suppurative Appendicitis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes